aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
EmboMedics, founded in 2012 and based in Maple Grove, Minnesota, develops and commercializes resorbable and drug-loaded embolization devices. Their products target multiple medical indications, aiming to improve patient outcomes through innovative, resorbable technology.
EmboMedics has made significant strides in the medical device industry, contributing to advancements in embolization treatments. Their pioneering work in resorbable devices has positioned them as a key player in the market, enhancing therapeutic options for various conditions.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Medical Devices
Technology
Biotech
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was EmboMedics founded?
EmboMedics was founded in 2012.
Where is EmboMedics’s headquarters located?
EmboMedics’s headquarters is located in Maple Grove, MN, US.
When was EmboMedics’s last funding round?
EmboMedics’s most recent funding round was for $750k (USD) in April 2018.
How many employees does EmboMedics have?
EmboMedics has 5 employees as of Feb 5, 2024.
How much has EmboMedics raised to-date?
As of July 05, 2023, EmboMedics has raised a total of $7.6M (USD) since Apr 25, 2018.
Add Comparison
Total Raised to Date
$7.6M
USD
Last Update Apr 25, 2018
Last Deal Details
$750k
USD
Apr 25, 2018
Series Unknown
Total Employees Over Time
5
As of Feb 2024
EmboMedics Address
17127 80th Place North
Maple Grove,
Minnesota
55311
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts